tiprankstipranks
Trending News
More News >
Galera Therapeutics (GRTX)
OTHER OTC:GRTX
US Market

Galera Therapeutics (GRTX) Income Statement

Compare
261 Followers

Galera Therapeutics Income Statement

Last quarter (Q3 2025), Galera Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Galera Therapeutics's net income was $-1.39M. See Galera Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -3.84M$ -259.00K$ -114.00K$ -778.00K$ -368.00K
Operating Expenses
$ 14.15M$ 46.69M$ 51.23M$ 73.37M$ 70.55M
Depreciation and Amortization
$ 20.00K$ 259.00K$ 114.00K$ 778.00K$ 368.00K
EBITDA
$ -20.16M$ -70.24M$ -50.61M$ -72.56M$ -69.01M
Operating Income
$ -20.16M$ -46.95M$ -51.23M$ -73.37M$ -70.55M
Other Income/Expenses
$ 1.00M$ -12.13M$ -11.07M$ -7.17M$ -3.68M
Pretax Income
$ -19.16M$ -59.08M$ -62.29M$ -80.53M$ -74.23M
Net Income
$ -18.96M$ -59.08M$ -62.22M$ -80.53M$ -74.22M
Per Share Metrics
Basic EPS
$ -0.35$ -1.33$ -2.30$ -3.40$ -2.98
Diluted EPS
$ -0.35$ -1.33$ -2.30$ -3.40$ -2.98
Weighted Average Shares Outstanding
54.63M 44.55M 27.09M 25.79M 24.87M
Weighted Average Shares Outstanding (Diluted)
54.63M 44.55M 27.09M 25.79M 24.87M
Currency in USD

Galera Therapeutics Earnings and Revenue History